← Explorer/Network

Fish oil attenuates the expression of the CCL2 chemokine and histone-modifying enzymes in LPS-stimulated human preadipocytes

Jussara de Jesus Simão, A Bispo, Victor Tadeu Gonçalves Plata +4 more2024Metabolism OpenJournal Article
10.1016/j.metop.2024.100336PubMedFree full text
Endocrine (ADH/ACTH/MSH)Immune/Innate
Bacterial Endotoxins

Abstract

In obesity, C-C chemokine ligand 2 (CCL2) plays a critical role in recruiting macrophages to white adipose tissue (WAT), contributing to chronic inflammation. In this study, we sought to explore the effects of fish oil (FO) on CCL2 expression and histone (H3K27)-modifying enzymes in both human model of preadipocytes and primary adipose-derived stem cells (ASCs). Present findings in preadipocytes lineage evidenced that lipopolysaccharide (LPS) increased TNF-alpha (∼5.8-fold) and CCL2 (∼3.8-fold) expression, modulating H3K27 modifying enzymes expression, including KDM6B and EP300. FO, in turn, significantly attenuated LPS-induced CCL2 expression and secretion and downregulated KDM6B and EP300, elucidating an important mechanism of action involved in the anti-inflammatory role of FO. We next isolated mature hypertrophied adipocytes from patient with overweight and exposed to LPS, resulting in increased CCL2/MCP-1 (∼3.8-fold) and TNF-alpha (∼4.5-fold) expression, effects significantly attenuated by FO. We also generated adipocyte-conditioned medium (ACM) and exposed ASCs to LPS or ACM for up to 72 h to assess CCL2/MCP-1 secretion. ACM from hypertrophied adipocytes stimulated increased CCL2/MCP-1 expression, which was partially reduced by FO. LPS treatment of primary ASCs led to a marked increase in CCL2 secretion, which was completely abolished by FO after 6 h, highlighting its potent anti-inflammatory effect. After 72 h, FO consistently maintained lower levels of CCL2, even during sustained inflammatory stimulation, underscoring its ability to modulate chronic inflammation. Additionally, the inhibition of NF-κB with JSH-23 mimicked the effects of FO on CCL2 expression, further suggesting that the anti-inflammatory actions of FO may involve NF-κB signaling. In conclusion, FO attenuates CCL2 expression and secretion in both preadipocytes and ASCs, providing evidence of its potential in modulating inflammation in WAT progenitor cells by modulating histone-modifying enzymes and inflammatory pathways.

Key Biomarkers

TNF-α

Symptom Clusters

Chronic inflammation

References (2)

  • Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistanceAmerican Journal of Physiology-Endocrinology and Metabolism · 2001
  • Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience · 1993

Related Papers

  • Investigating the effect of a low carbohydrate, high saturated fat diet on concentration levels of markers associated with a leaky gut and the association with glucose homeostasisResearch Square · 2023 · 3 shared tags
  • TREM-1 governs NLRP3 inflammasome activation of macrophages by firing up glycolysis in acute lung injuryInternational Journal of Biological Sciences · 2022 · 3 shared tags
  • The gut microbiota2023 · 3 shared tags
  • Hesperetin suppresses LPS/high glucose-induced inflammatory responses via TLR/MyD88/NF-κB signaling pathways in THP-1 cellsNutrition Research and Practice · 2021 · 3 shared tags
  • Treatable metabolic and inflammatory abnormalities in Post COVID Syndrome (PCS) define the transcriptomic basis for persistent symptoms: Lessons from CIRSMedical Research Archives · 2021 · 3 shared tags
  • Newer Molecular Methods Bring New Insights into Human- And Building-Health Risk Assessments from Water-Damaged Buildings: Defining Exposure and Reactivity, the Two Sides of Causation of CIRS-WDB Illness
Medical Research Archives · 2021 · 3 shared tags